Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- D.C. United’s Danita Johnson Becomes First Woman To Join Buzzer’s Board Of Directors also categorized in BoardMoves
- Tempur Sealy Settles With Hedge Fund H Partners After CEO Ouster also written by Antoine Gara
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Berkshire Hathaway Wannabe Turning Into A Quagmire For Investors also written by Antoine Gara
- The CIO-Plus Of Vivint Smart Home Named To The Board Of Domo also categorized in BoardMoves
- No Sleep Till Activism: Hedge Fund H Partners Wins Mattress Company Fight also written by Antoine Gara
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- DuPont Spinoff Fans Flames In Trian Management's Scorched Earth Fight also written by Antoine Gara
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
Login to comment.